149 related articles for article (PubMed ID: 33138824)
1. The values of AHCY and CBS promoter methylation on the diagnosis of cerebral infarction in Chinese Han population.
Li X; Bu S; Pan RR; Zhou C; Qu K; Ying X; Zhong J; Xiao J; Yuan Q; Zhang S; Tipton L; Wang Y; Deng Y; Duan S
BMC Med Genomics; 2020 Nov; 13(1):163. PubMed ID: 33138824
[TBL] [Abstract][Full Text] [Related]
2. PON1 Hypermethylation and PON3 Hypomethylation are Associated with Risk of Cerebral Infarction.
Xiao J; Li X; Yuan Q; Zhang S; Qu K; Wu B; Wang Y; Duan S
Curr Neurovasc Res; 2019; 16(2):115-122. PubMed ID: 30977447
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of AHCY may increase the risk of ischemic stroke.
Zhao L; Chen X; Zhou S; Lin Z; Yu X; Huang Y
Bosn J Basic Med Sci; 2020 Nov; 20(4):471-476. PubMed ID: 32020847
[TBL] [Abstract][Full Text] [Related]
4. A Preliminary Study of the Association between Apolipoprotein E Promoter Methylation and Atherosclerotic Cerebral Infarction.
Zhang H; Zhao X; Wang C; Du R; Wang X; Fu J; Sun Q
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1056-1061. PubMed ID: 30658954
[TBL] [Abstract][Full Text] [Related]
5. CBS gene polymorphism and promoter methylation-mediating effects on the efficacy of folate therapy in patients with hyperhomocysteinemia.
Zhao Q; Zhang C; Li D; Huang X; Ren B; Yue L; Du B; Godfrey O; Zhang W
J Gene Med; 2020 Apr; 22(4):e3156. PubMed ID: 31864233
[TBL] [Abstract][Full Text] [Related]
6. CBS promoter hypermethylation increases the risk of hypertension and stroke.
Wang C; Xu G; Wen Q; Peng X; Chen H; Zhang J; Xu S; Zhang C; Zhang M; Ma J; Hui Z; Wu G; Ma M
Clinics (Sao Paulo); 2019 Mar; 74():e630. PubMed ID: 30916171
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive association analysis between homocysteine metabolic pathway gene methylation and ischemic stroke in a Chinese hypertensive population.
Li B; Li Y; Xu S; Chen H; Dai S; Peng X; Wang L; Liang Y; Li C; Tang B; Zhu L; Zhang T; Lv C; Wang C; Han L
J Clin Lab Anal; 2021 Mar; 35(3):e23689. PubMed ID: 33382484
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
Tu XH; Huang SX; Li WS; Song JX
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
[TBL] [Abstract][Full Text] [Related]
9. Association between BHMT and CBS gene promoter methylation with the efficacy of folic acid therapy in patients with hyperhomocysteinemia.
Huang X; Li D; Zhao Q; Zhang C; Ren B; Yue L; Du B; Godfrey O; Wang X; Zhang W
J Hum Genet; 2019 Dec; 64(12):1227-1235. PubMed ID: 31558761
[TBL] [Abstract][Full Text] [Related]
10. CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population.
Li B; Chen X; Jiang Y; Yang Y; Zhong J; Zhou C; Hu H; Duan S
Immunol Lett; 2017 Oct; 190():15-19. PubMed ID: 28690186
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia induced endothelial progenitor cells dysfunction through hyper-methylation of CBS promoter.
Behera J; Tyagi SC; Tyagi N
Biochem Biophys Res Commun; 2019 Feb; 510(1):135-141. PubMed ID: 30683311
[TBL] [Abstract][Full Text] [Related]
12. [The role of thromboxane A2 receptor gene promoter polymorphism in acute cerebral infarction].
Wang Y; Mao L; Lin B; Zhang Y; Tao T; Qi Y; Lin X; Jin J; Huang R; Yan Z; Wen S; Zhang D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):309-14. PubMed ID: 24809258
[TBL] [Abstract][Full Text] [Related]
13. Gout in males: a possible role for COMT hypomethylation.
Ying X; Chen Y; Zheng Z; Duan S
Clin Rheumatol; 2019 Oct; 38(10):2865-2871. PubMed ID: 31165340
[TBL] [Abstract][Full Text] [Related]
14. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
[TBL] [Abstract][Full Text] [Related]
15. Mapping of DNA Hypermethylation and Hypomethylation induced by Folate Deficiency in Sporadic Colorectal Cancer and Clinical Implication Analysis of Hypermethylation Pattern in CBS Promoter.
Zhang Z; He Y; Tu X; Huang S; Chen Z; Wang L; Song J
Clin Lab; 2017 Apr; 63(4):733-748. PubMed ID: 28397458
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J
PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypomethylation of microRNA223 gene is associated with atherosclerotic cerebral infarction.
Li Z; Yu F; Zhou X; Zeng S; Zhan Q; Yuan M; Yang Q; Liu Y; Xia J
Atherosclerosis; 2017 Aug; 263():237-243. PubMed ID: 28683362
[TBL] [Abstract][Full Text] [Related]
18. Short tandem repeats and methylation in the promoter region affect expression of cystathionine beta-synthase gene in the laying hen.
Zhou R; de Koning DJ; McCormack H; Wilson P; Dunn I
Gene; 2019 Aug; 710():367-374. PubMed ID: 31145961
[TBL] [Abstract][Full Text] [Related]
19. S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice.
Lee HO; Wang L; Kuo YM; Andrews AJ; Gupta S; Kruger WD
Mol Genet Metab Rep; 2018 Jun; 15():15-21. PubMed ID: 30023284
[TBL] [Abstract][Full Text] [Related]
20. Significant association of PRMT6 hypomethylation with colorectal cancer.
Pan R; Yu H; Dai J; Zhou C; Ying X; Zhong J; Zhao J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Duan S
J Clin Lab Anal; 2018 Nov; 32(9):e22590. PubMed ID: 29927001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
